ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...

Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, ...

Recent research from Michigan Medicine takes aim at the a variant in gene SCN1B, which causes a severe form of developmental epileptic encephalopathy.

Researchers find a master epigenetic switch that activates silenced genes to compensate for their missing counterparts in a ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

All other programs remain on track; IND filings expected in 2025 for GBA1 and FA programs - LEXINGTON, Mass., (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company ...

Using “cure” to refer to “obtaining a normal life” also fits — if you ignore previously lost education, career opportunities ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Senti Bio aims to improve cancer therapeutics with customizable gene circuits, or multi-gene constructs capable of ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.